Stouten V, Westhovens R, Pazmino S, De Cock D, et al. Response to: 'Correspondence on 'Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial'' by Jain and Dhir et al. Ann Rheum Dis 2021 Jun 30. pii: annrheumdis-2021-220857.
PMID: 34193403